Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
iSpecimen ( (ISPC) ) has provided an update.
On June 18, 2025, Richard J. Paolone and John L. Brooks III resigned from the Board of Directors of iSpecimen Inc., with no disagreements cited regarding company operations or policies. Subsequently, on June 20, 2025, Anthony Lau was appointed to the Board, bringing extensive experience in corporate governance and financial oversight, which is expected to enhance the company’s governance and oversight capabilities.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Underperform.
The overall stock score is primarily impacted by poor financial performance, negative valuation metrics, and technical analysis indicating bearish trends. The additional risk of Nasdaq non-compliance raises concerns about the company’s stability and future trading prospects.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
Average Trading Volume: 78,418
Technical Sentiment Signal: Sell
Current Market Cap: $2.4M
See more data about ISPC stock on TipRanks’ Stock Analysis page.